Mice with a targeted mutation in lymphotoxin-α exhibit enhanced tumor growth and metastasis: Impaired NK cell development and recruitment

Journal of Immunology

Volumn 163, Issue 5, 1999, Pages 2809-2815

  Ito, Daisuke ^a   Back, Timothy C ^b   Shakhov, Alexander N ^a,b   Wiltrout, Robert H ^a   Nedospasov, Sergei A ^a,b,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL COUNT; CELL MATURATION; GENE MUTATION; GERMINAL CENTER; IMMUNOSURVEILLANCE; LYMPH FOLLICLE; LYMPH NODE; LYMPHOCYTE PROLIFERATION; METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; BONE MARROW CELLS; CARCINOMA, LEWIS LUNG; CELL DIVISION; CELL MOVEMENT; CYTOTOXICITY, IMMUNOLOGIC; HEMATOPOIETIC STEM CELLS; IMMUNOLOGIC DEFICIENCY SYNDROMES; KILLER CELLS, NATURAL; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOTOXIN-ALPHA; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTAGENESIS, SITE-DIRECTED; ORGAN SPECIFICITY; SPLEEN;

EID: 0033198122     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Paul, N. L., and N. H. Ruddle. 1988. Lympholoxin. Annu. Rev. Immunol. 6:407.
2. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959.
3. Ware, C. F., P. D. Crowe, M. H. Grayson, M. J. Androlewicz, and J. L. Browning. 1992. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. J. Immunol. 149:3881.
4. Browning, J. L., A. Ngam-ek, P. Lawton, J. DeMarinis, R. Tizard, E. P. Chow, C. Hession, B. O'Brine-Greco, S. F. Foley, and C. F. Ware. 1993. Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72:847.
5. Crowe, P. D., T. L. VanArsdale, B. N. Walter, C. F. Ware, C. Hession, B. Ehrenfels, J. L. Browning, W. S. Din, R. G. Goodwin, and C. A. Smith. 1994. A lymphotoxin-β-specific receptor. Science 264:707.
6. De Togni, P., J. Goellner, N. H. Ruddle, P. R. Streeter, A. Fick, S. Mariathasan, S. C. Smith, R. Carlson, L. P. Shornick, J. Strauss-Schoenberger, et al. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264:703.
7. Futterer, A., K. Mink, A. Luz, M. H. Kosco-Vilbois, and K. Pfeffer. 1998. The lymphotoxin β receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 9:59.
8. Fu, Y. X., G. Huang, Y. Wang, and D. D. Chaplin. 1998. B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin α-dependent fashion. J. Exp. Med. 187:1009.
9. Alimzhanov, M. B., D. V. Kuprash, M. H. Kosco-Vilbois, A. Luz, R. L. Turetskaya, A. Tarakhovsky, K. Rajewsky, S. A. Nedospasov, and K. Pfeffer. 1997. Abnormal development of secondary lymphoid tissues in lymphotoxin β-deficient mice. Proc. Natl. Acad. Sci. USA 94:9302.
10. Koni, P. A., R. Sacca, P. Lawton, J. L. Browning, N. H. Ruddle, and R. A. Flavell. 1997. Distinct roles in lymphoid organogenesis for lymphotoxins α and βrevealed in lymphotoxin β-deficient mice. Immunity 6:491.
11. Banks, T. A., B. T. Rouse, M. K. Kerley, P. J. Blair, V. L. Godfrey, N. A. Kuklin, D. M. Bouley, J. Thomas, S. Kanangat, and M. L. Mucenski. 1995. Lymphotoxin-α-deficient mice: effects on secondary lymphoid organ development and humoral immune responsiveness. J. Immunol. 155:1685.
12. Matsumoto, M., S. Mariathasan, M. H. Nahm, F. Baranyay, J. J. Peschon, and D. D. Chaplin. 1996. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science 271:1289.
13. Fu, Y. X., H. Molina, M. Matsumoto, G. Huang, J. Min, and D. D Chaplin. 1997. Lymphotoxin-α (LTα) supports development of splenic follicular structure that is required for IgG responses. J. Exp. Med. 185:2111.
14. Fu, Y. X., G. Huang, M. Matsumoto, H. Molina, and D. D. Chaplin. 1997. Independent signals regulate development of primary and secondary follicle structure in spleen and mesenteric lymph node. Proc. Natl. Acad. Sci. USA 94: 5739.
15. Sacca, R., S. Turley, L. Soong, I. Mellman, and N. H. Ruddle. 1997. Transgenic expression of lymphotoxin restores lymph nodes to lymphotoxin-α-deficient mice. J. Immunol. 159:4252.
16. Koni, P. A., and R. A. Flavell. 1998. A role for tumor necrosis factor receptor type 1 in gut-associated lymphoid tissue development: genetic evidence of synergism with lymphotoxin β. J. Exp. Med. 187:1977.
17. + cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7:493.
18. Rennert, P. D., D. James, F. Mackay, J. L. Browning, and P. S. Hochman. 1998. Lymph node genesis is induced by signaling through the lymphotoxin βreceptor. Immunity 9:71.
19. Mackay, F., and J. L. Browning. 1998. Turning off follicular dendritic cells. Nature 395:26.
20. Mackay, F., G. R. Majeau, P. Lawton, P. S. Hochman, and J. L. Browning. 1997. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur. J. Immunol. 27:2033.
21. Twilley, T. A., L. Mason, J. E. Talmadge, and R. H. Wiltrout. 1987. Increase in liver-associated natural killer activity by polyribonucleotides. Nat. Immun. Cell Growth Regul. 6:279.
22. Dong, Z., J. Yoneda, R. Kumar, and I. J. Fidler. 1998. Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 188:755.
23. Fogler, W. E., K. Volker, K. L. McCormick, M. Watanabe, J. R. Ortaldo, and R. H. Wiltrout. 1996. NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. J. Immunol. 156:4707.
24. Watanabe, M., K. L. McCormick, K. Volker, J. R. Ortaldo, J. M. Wigginton, M. J. Brunda, R. H. Wiltrout, and W. E. Fogler. 1997. Regulation of local host-mediated anti-tumor mechanisms by cytokines: direct and indirect effects on leukocyte recruitment and angiogenesis. Am. J. Pathol 150:1869.
25. Talmadge, J. E., K. M. Meyers, D. J. Prieur, and J. R. Starkey. 1980. Role of NK cells in tumour growth and metastasis in beige mice. Nature 284:622.
26. Wiltrout, R. H., R. B. Herberman, S. R. Zhang, M. A. Chirigos, J. R. Ortaldo, K. M. Green, Jr., and J. E. Talmadge. 1985. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J. Immunol. 134:4267.
27. Zheng, L. M., D. M. Ojcius, F. Garaud, C. Roth, E. Maxwell, Z. Li, H. Rong, J. Chen, X. Y. Wang, J. J. Catino, and I. King. 1996. Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism. J. Exp. Med. 184:579.
28. Hafner, M., P. Orosz, A. Kruger, and D. N. Mannel. 1996. TNF promotes metastasis by impairing natural killer cell activity. Int. J. Cancer 66:388.
29. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
30. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkemagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
31. Henkart, P. A. 1994. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1:343.
32. Berke, G. 1997. The Fas-based mechanism of lymphocytotoxicity. Hum. Immunol. 54:1.
33. van den Broek, M. F., D. Kagi, R. M. Zinkemagel, and H. Hengartner. 1995. Perform dependence of natural killer cell-mediated tumor control in vivo. Eur. J. Immunol. 25:3514.
34. Sayers, T. J., A. D. Brooks, J. K. Lee, R. G. Fenton, K. L. Komschlies, J. M. Wigginton, R. Winkler-Pickett, and R. H. Wiltrout. 1998. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells. J. Immunol. 161:3957.
35. Wiltrout, R. H., A. M. Pilaro, M. E. Grays, J. E. Talmadge, D. L. Longo, J. R. Ortaldo, and C. W. Reynolds. 1989. Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow. J. Immunol. 143:372.
36. Pilaro, A. M., D. D. Taub, K. L. McCormick, H. M. Williams, T. J. Sayers, W. E. Fogler, and R. H. Wiltrout. 1994. TNF-α is a principal cytokine involved in the recruitment of NK cells to liver parenchyma. J. Immunol. 153:333.
37. Barton, K., N. Muthusamy, C. Fischer, C. N. Ting, T. L. Walunas, L. L. Lanier, and J. M. Leiden. 1998. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 9:555.
38. Browning, J. L., I. Dougas, A. Ngam-ek, P. R. Bourdon, B. N. Ehrenfels, K. Miatkowski, M. Zafari, A. M. Yampaglia, P. Lawton, and W. Meier. 1995. Characterization of surface lymphotoxin forms: use of specific monoclonal antibodies and soluble receptors. J. Immunol. 154:33.
39. Browning, J. L., K. Miatkowski, I. Sizing, D. Griffiths, M. Zafari, C. D. Benjamin, W. Meier, and F. Mackay. 1996. Signaling through the lymphotoxin β receptor induces the death of some adenocarcinoma tumor lines. J. Exp. Med. 183:867.
40. Mackay, F., P. R. Bourdon, D. A. Griffiths, P. Lawton, M. Zafari, I. D. Sizing, K. Miatkowski, A. Ngam-ek, C. D. Benjamin, C. Hession, et al. 1997. Cytotoxic activities of recombinant soluble murine lympholoxin-α and lymphotoxin-αβ complexes. J. Immunol. 159:3299.
41. Reisfeld, R. A., S. D. Gillies, J. Mendelsohn, N. M. Varki, and J. C. Becker. 1996. Involvement of B lymphocytes in the growth inhibition of human pulmonary melanoma metastases in athymic nu/nu mice by an antibody-lympholoxin fusion protein. Cancer Res. 56:1707.
42. Hisano, G., and N. Hanna. 1982. Murine lymph node natural killer cells: regulatory mechanisms of activation or suppression. J. Natl. Cancer Inst. 69:665.
43. Lim, Y. S., B. Y. Kang, E. J. Kim, S. H. Kim, S. Y. Hwang, and T. S. Kim. 1998. Augmentation of therapeutic atititumor immunity by B16F10 melanoma cells transfected by interferon-γ and allogeneic MHC class I cDNAs. Mol. Cells 8:629.
44. Karavodin, L. M., J. Robbins, K. Chong, D. Hsu, C. Ibanez, S. Mento, D. Jolly, and T. C Fong. 1998. Generation of a systemic antitumor response with regional intratumoral injections of interferon γ retroviral vector. Hum. Gene Ther. 9:2231.
45. Fleischmann, C. M., T. Y. Wu, and W. R. J. Fleischmann. 1997. B16 melanoma cells exposed in vitro to long-term IFN-α treatment (B 16 α cells) as activators of tumor immunity in mice. J. Interferon Cytokine Res. 17:37.
46. Bohm, W., S. Thoma, F. Leithauser, P. Moller, R. Schirmbeck, and J. Reimann. 1998. T cell-mediated, IFN-γ-facililated rejection of murine B16 melanomas. J. Immunol. 161:897.
47. Tanaka, K., E. Gorelik, M. Watanabe, N. Hozumi, and G. Jay. 1988. Rejection of B16 melanoma induced by expression of a transfected major histocompatibility complex class I gene. Mol. Cell Biol. 8:1857.
48. Okahara, H., H. Yagita, K. Miyake, and K. Okumura. 1994. Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor α enhancement of experimental metastasis. Cancer Res. 54:3233.
49. Smyth, M. J., J. M. Kelly, A. G. Baxter, H. Korner, and J. D. Sedgwick. 1998. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum. J. Exp. Med. 188:1611.
50. Osaki, T., J. M. Peron, Q. Cai, H. Okamura, P. D. Robbins, M. Kurimoto, M. T. Lotze, and H. Tahara. 1998. IFN-γ-inducing factor/IL-18 administration mediates IFN-γ- and IL-12-independent antitumor effects. J. Immunol. 160:1742.
51. Hultgren, O., H. P. Engster, J. D. Sedgwick, H. Korner, and A. Tarkowski. 1998. TNF/lymphotoxin-α double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus. J. Immunol. 161:5937.
52. Frei, K., H. P. Eugster, M. Bopst, C. S. Constantinescu, E. Lavi, and A. Fontana. 1997. Tumor necrosis factor α and lymphotoxin α are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 185:2177.
53. Suen, W. E., C. M. Bergman, P. Hjelmstrom, and N. H. Ruddle. 1997. A critical role for lymphotoxin in experimental allergic encephalomyelitis. J. Exp. Med. 186:1233.
54. Kimura, K., Y. Abe, A. Horiuchi, M. Miyake, and S. Kimura. 1995. Membrane-associated lymphotoxin-expressing lymphokine-activated killer cells up-regulate intercellular adhesion molecule-1 expression on target tumor cells in vitro. Cell Immunol. 164:119.